158 related articles for article (PubMed ID: 1653493)
1. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
Altmeyer R; Murdin AD; Harber JJ; Wimmer E
Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
[TBL] [Abstract][Full Text] [Related]
2. The effect of site and mode of expression of a heterologous antigenic determinant on the properties of poliovirus hybrids.
Murdin AD; Mirzayan C; Kameda A; Wimmer E
Microb Pathog; 1991 Jan; 10(1):27-37. PubMed ID: 1713280
[TBL] [Abstract][Full Text] [Related]
3. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.
Murdin AD; Wimmer E
J Virol; 1989 Dec; 63(12):5251-7. PubMed ID: 2479772
[TBL] [Abstract][Full Text] [Related]
4. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of antigenic hybrids of poliovirus.
Murdin AD; Kameda A; Murray MG; Wimmer E
Microb Pathog; 1991 Jan; 10(1):39-45. PubMed ID: 1649944
[TBL] [Abstract][Full Text] [Related]
6. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
Martin A; Wychowski C; Benichou D; Crainic R; Girard M
Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
Murray MG; Bradley J; Yang XF; Wimmer E; Moss EG; Racaniello VR
Science; 1988 Jul; 241(4862):213-5. PubMed ID: 2838906
[TBL] [Abstract][Full Text] [Related]
8. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
9. Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F; Van Wezel E; Blondel B; Crainic R
J Virol; 1990 Dec; 64(12):6090-100. PubMed ID: 2173781
[TBL] [Abstract][Full Text] [Related]
10. Isolation of escape mutants of a hybrid poliovirus with the aid of insert-specific polyclonal antibodies.
Hovi T; Huovilainen A; Murdin A; Wimmer E
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1861-5. PubMed ID: 9049393
[TBL] [Abstract][Full Text] [Related]
11. A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.
Murdin AD; Su H; Manning DS; Klein MH; Parnell MJ; Caldwell HD
Infect Immun; 1993 Oct; 61(10):4406-14. PubMed ID: 7691749
[TBL] [Abstract][Full Text] [Related]
12. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
13. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
[TBL] [Abstract][Full Text] [Related]
14. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
15. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.
Murray MG; Kuhn RJ; Arita M; Kawamura N; Nomoto A; Wimmer E
Proc Natl Acad Sci U S A; 1988 May; 85(9):3203-7. PubMed ID: 2834736
[TBL] [Abstract][Full Text] [Related]
17. Functional conservation of the hydrophobic domain of polypeptide 3AB between human rhinovirus and poliovirus.
Towner JS; Brown DM; Nguyen JH; Semler BL
Virology; 2003 Sep; 314(1):432-42. PubMed ID: 14517095
[TBL] [Abstract][Full Text] [Related]
18. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
19. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
20. An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16.
Jenkins O; Cason J; Burke KL; Lunney D; Gillen A; Patel D; McCance DJ; Almond JW
J Virol; 1990 Mar; 64(3):1201-6. PubMed ID: 2154604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
